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Abstract: 2-Aminopyridine is an important compound, which is used as intermediate for the synthesis of pharmaceutical 
compounds. The present work was aimed to assess the effect of Mr. Trivedi’s biofield energy treatment on the physical, 
thermal and spectral characteristics of 2-AP. The work was accomplished by dividing the sample in two parts i.e. one part was 
remained untreated, and another part had received biofield energy treatment. Subsequently, the samples were analyzed using 
various characterization techniques such as X-ray diffraction, differential scanning calorimetry, thermogravimetric analysis, 
ultra violet-visible spectroscopy, and Fourier transform infrared spectroscopy. The XRD analysis revealed a decrease in 
crystallite size of the treated sample (91.80 nm) as compared to the control sample (97.99 nm). Additionally, the result showed 
an increase in Bragg’s angle (2θ) of the treated sample as compared to the control. The DSC and Differential thermal analysis 
analysis showed an increase in melting temperature of the treated 2-AP with respect to the control. Moreover, the latent heat of 
fusion of the treated sample was increased by 3.08%. The TGA analysis showed an increase in onset of thermal degradation 
(Tonset), and maximum thermal decomposition temperature (Tmax) of the treated 2-AP as compared to the control sample. 
Additionally, the treated sample showed a reduction in weight loss as compared with the control indicating higher thermal 
stability of the sample. UV-visible analysis showed no changes in the absorption peak of the treated sample as compared to the 
control. The FT-IR spectroscopic results showed downward shifting of C-H stretching vibration 2991→2955 cm-1 in treated 
sample with respect to the control. 
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1. Introduction 
Aminopyridines are an important class of compounds used 
as a research tool for characterizing subtypes of the 
potassium channel [1]. 4-Aminopyridine or fampridine is 
used as a drug for symptomatic treatment of multiple 
sclerosis and it is believed to improve the walking in adults 
with several variations of the disease [1, 2]. It acts by 
blocking the potassium channels and prolong the action 
potentials, thereby releases neurotransmitters at the 
neuromuscular junction [3]. 2-Aminopyridine (2-AP) is one 
of the isomers of aminopyridines and it has been used for the 
synthesis of pharmaceutical agents [4]. 2-AP is a colourless 
solid used in the production of piroxicam, which is used as a 
non-steroidal anti-inflammatory drug (NSAID) to relieve the 
symptoms of painful, inflammatory conditions like arthritis 
[5, 6]. It has been used as an intermediate for the synthesis of 
pharmaceutical agents such as sulfapyridine, tenoxicam, and 
tripelennamine [4]. Recently Gonzalez Cabrera et al. [7] and 
Younis et al. [8, 9] synthesized the 2-AP derivatives as 
potential anti-malarial candidates, and they evaluated its 
efficiency in Plasmodium berghei infected mouse model. 
Dambuza et al. also reported the antimalarial properties of 
3,5-Diaryl-2-aminopyridine derivatives [10]. Moreover, 2-AP 
based compounds have been evaluated for the treatment of 
Alzheimer’s and neuro vascular diseases [11].  
Pharmaceutical analysis and stability are required to 
validate the potency, identity and purity of the ingredients as 
well as those of the formulated products [12]. The stability of 
pharmaceutical agents is known as the capability of a 
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formulation in a container to remain within its physical, 
chemical, microbiological, and toxicological specifications 
[13]. Thus, novel methods should be explored in order to 
improve the pharmaceutical stability of the drugs. Recently 
biofield energy treatment was used as a lucrative approach 
for modification of the physicochemical properties of various 
materials such as organic compounds [14] drugs [15], and 
polymers [16]. 
Biofield energy treatment is a healing technique where life 
force energy is transmitted to a person’s biofield (energy 
body) by a practitioner. Further, the human biofield is also 
referred as an energetic field or matrix that surrounds the 
human body. This energetic field is identical to superhighway 
that allows the DNA in cells to communicate faster than light 
and maintain coherent, holistic intelligence in the organism 
[17]. Thus, it is envisaged that human beings have the ability 
to harness the energy from the environment/Universe and can 
transmit into any object (living or non-living) around the 
Globe. The object(s) will always receive the energy and 
responding in a useful manner that is called biofield energy. 
Moreover, biofield energy treatment which comes under the 
category of Complementary and Alternative Medicine 
(CAM) therapies have been approved by the prestigious 
National Institute of Health (NIH)/The National Centre for 
Complementary and Alternative Medicine (NCCAM), as an 
alternative treatment in the healthcare sector [18].  
Mr. Mahendra Kumar Trivedi is a well-known healer of 
biofield energy therapy who can alter the characteristics of 
living and non-living things. The biofield treatment has 
improved the growth and production of agriculture crops [19] 
and significantly altered the phenotypic characteristics of 
various pathogenic microbes [20]. This unique biofield 
energy treatment is also known as The Trivedi Effect®. 
Hence, by considering the excellent outcomes from biofield 
energy treatment and pharmaceutical properties of 2-AP, this 
research work was undertaken to investigate the impact of 
biofield energy treatment on the physical, thermal and 
spectral properties of this compound. The control and treated 
samples were analysed for their physicochemical properties 
using various analytical techniques such as X-ray diffraction, 
differential scanning calorimetry, thermogravimetric analysis, 
ultra violet-visible spectroscopy analysis, and Fourier 
transform infrared spectroscopy. 
2. Experimental 
2.1. Materials 
2-Aminopyridine was procured from S D Fine Chemicals 
Ltd., India. 
2.2. Methods 
The sample was divided into two parts: control and treated. 
One part was kept aside as a control sample while the other 
part was subjected to Mr. Trivedi’s biofield energy treatment 
and labelled as treated sample. The treated group was in 
sealed pack and handed over to Mr. Trivedi for biofield 
energy treatment. Mr. Trivedi given the energy treatment 
through his energy transmission process to the treated group 
without touching the sample under laboratory conditions.  
2.3. X-Ray Diffraction (XRD) 
XRD analysis of control and treated 2-AP was evaluated 
using X-ray diffractometer system, Phillips, Holland PW 
1710 which consist of a copper anode with nickel filter. XRD 
system had a radiation of wavelength 1.54056 Å. The 
average crystallite size (G) was computed using formula:  
G = kλ/(bCosθ)                               (1) 
Here, λ is the wavelength of radiation used, b is full-width 
half-maximum (FWHM) of peaks and k is the equipment 
constant.  
Percentage change in crystallite size was calculated as:  
[(Gt-Gc)/Gc]×100                            (2) 
Where, Gc and Gt are denoted as crystallite size of control 
and treated powder samples, respectively.  
2.4. Differential Scanning Calorimetry (DSC) 
The control and treated 2-AP samples were analyzed using 
Pyris-6 Perkin Elmer DSC at a heating rate of 10°C /min and 
the air was purged at a flow rate of 5 mL/min. The 
predetermined amount of sample was kept in an aluminum 
pan and closed with a lid. A reference sample was prepared 
using a blank aluminum pan. The percentage change in latent 
heat of fusion was calculated using following equations: 
[∆H Treated - ∆H Control]/ ∆H Control × 100                 (3) 
Where, ∆H Control and ∆H Treated are the latent heat of fusion 
of control and treated samples, respectively.  
2.5. Thermogravimetric Analysis-Differential Thermal 
Analysis (TGA-DTA) 
A Mettler Toledo simultaneous TGA and differential 
thermal analyzer (DTA) was used to investigate the thermal 
stability of control and treated 2-AP samples. The rate of 
heating was 5°C /min and samples were heated in the range 
of 30- 400°C under air atmosphere.  
2.6. UV-Vis Spectroscopic Analysis 
A Shimadzu UV-2400 PC series spectrophotometer with 1 
cm quartz cell and a slit width of 2.0 nm was used to obtain 
the UV spectra of the control and treated 2-AP samples. The 
spectroscopic analysis was carried out using wavelength in 
the range of 200-400 nm and methanol was used as a solvent.  
2.7. FT-IR Spectroscopy 
The FT-IR spectra were recorded on Shimadzu’s Fourier 
transform infrared spectrometer (Japan) with the frequency 
range of 4000-500 cm-1. The biofield energy treated sample 
was divided in two parts T1 and T2 for the FT-IR analysis.  
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3. Results and Discussion 
3.1. XRD Study  
XRD is a non-destructive technique that is widely used to 
evaluate the crystalline nature of the materials. The XRD 
diffractograms of control and treated samples are shown in 
Fig. 1. The XRD diffractogram of the control sample showed 
intense peaks at 2θ equal to 13.68º, 15.10º, 15.23º, 19.17º, 
19.45º, 19.64º, 23.68º, 23.98º, 25.40º, 28.16º, 28.37º, 30.48º 
and 34.56º. However, the treated sample showed XRD peaks 
at 2θ equal to 14.81º, 15.03º, 15.41º, 19.03º, 19.23º, 21.57º, 
23.61º, 28.10º, 30.47º, and 34.40º. The result showed that 2θ 
peak originally present at 13.68º with lower intensity was 
shifted to 14.81º in the treated sample. Additionally, the XRD 
peak at 15.23º in control was also shifted to higher Braggs 
angle 15.41º in the treated 2-AP sample. It was reported that 
increase in 2θ peak mainly occurs due to stress in the sample. 
Namazu et al. during their studies on sputtered gold-tin 
eutectic film reported that as the tensile stress increases this 
causes XRD peak shift to the higher angle (2θ) [21]. Hence, 
it is assumed that tensile stress might be applied in the treated 
sample due to biofield energy treatment that caused an 
increase in 2θ angle of the XRD peak as compared to the 
control. 
The crystallite size was calculated using well-known 
Scherrer formula and results are reported in Fig. 2. The 
crystallite size of the control sample was 97.99 nm and it was 
decreased upto 91.80 nm (6.31%) in the treated sample. It 
was reported that the crystallite size directly influences the 
materials properties, and it is one of the crystallographic 
parameters linked with the formation of dislocations and 
point defects in a crystal structure [22]. Researchers have 
shown that magnitude of tensile stress is inversely 
proportional to the crystallite size [23, 24]. Schafer et al. and 
Schwarzbach et al. have experimentally demonstrated that 
increase in tensile stress causes a decrease in crystallite size 
of the materials [25, 26]. It is believed that tensile stress 
arises due to the interactions across grain boundaries when 
the grain starts to coalesce. Further, the grain exerts attractive 
atomic forces along the grain boundaries to minimize the 
surface energy but are forced by adhesion to the substrate, 
which results in tensile stress [27]. Therefore, it is 
hypothesized that the biofield energy treatment might cause 
attractive forces in the particle/grain boundaries of treated 2-
AP that reduced the surface energy and increased the tensile 
stress. This further led to a decrease in crystallite size of the 
treated sample as compared to the control.  
It was previously reported that nano scale particle size and 
small crystallite size can overcome slow diffusion rate by 
reducing the overall diffusion distance, and this ultimately 
enhances the net reaction rate [28, 29]. It is reported that the 
lower crystallite size can improve the reaction rate [30]. 
Hence, the reduced crystallite size after biofield treatment, 
may increase the reaction rate of 2-AP to be utilized for the 
synthesis of pharmaceutical compounds.  
 
Fig. 1. XRD diffractograms of control and treated 2-aminopyridine. 
 
Fig. 2. Crystallite size of control and treated 2-aminopyridine. 
3.2. Differential Scanning Calorimetry 
DSC is a thermal analysis technique that is widely used for 
evaluation of melting temperature, glass transition, and latent 
heat of fusion of the materials. The DSC thermograms of 
control and treated samples are shown in Fig. 3. The DSC 
graph of the control 2-AP showed a sharp endothermic peak 
at 60.90°C that was due to melting temperature of the 
sample. This was well supported by the reported melting 
temperature of pure 2-AP [4]. However, the DSC 
thermogram of treated 2-AP showed a melting endothermic 
peak at 61.32°C. This suggested the increase in melting 
temperature of the 2-AP after biofield energy treatment. It 
was previously reported that the melting temperature is the 
best descriptor of thermal stability of the compounds [31]. 
Hence, it is assumed that biofield treatment had perhaps 
caused an increase in thermal stability of the 2-AP.  
The latent heat of fusion of the control and treated sample 
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were obtained from the thermograms and data are presented 
in Table 1. The control sample showed the latent heat of 
fusion of 155.99 J/g and it was decreased slightly to 151.18 
J/g in the treated sample. The latent heat of fusion is the 
energy absorbed in a material during its phase change from 
solid to liquid. Hence, it is speculated that biofield energy 
treatment had perhaps alerted the stored energy in the treated 
sample that led to a decrease in latent heat of fusion of the 
treated 2-AP as compared to the control.  
 
Fig. 3. DSC thermograms of control and treated 2-aminopyridine. 
3.3. TGA Analysis 
TGA is a thermal analysis technique that gives vital 
information about the thermal stability, oxidation, 
sublimation and thermal decomposition of the materials. The 
thermal decomposition of the control sample started at 
around 112°C, and it stopped at 158°C. Whereas, the treated 
sample showed thermal decomposition at around 150°C, and 
it terminated at 190°C. Both the control and treated samples 
lost 67.01 and 44.64%, respectively from its initial weight 
during this process. The low weight loss of the treated 2-AP 
was associated with increased thermal stability of the sample 
as compared to the control.  
DTA thermograms of the control and treated samples are 
presented in Fig. 4. The DTA thermogram of the control 
sample exhibited two endothermic transitions at 60.16°C and 
142.98°C. The former endothermic peak was due to melting 
temperature of the untreated sample. The later peak was 
might be due to thermal decomposition or volatilization of 
the control sample. Similarly, the treated sample also 
exhibited two endothermic peaks at 63.27°C and 172.50°C. 
The first endothermic peak was due to melting and the 
second peak was due to volatilization temperature of the 
treated 2-AP. The results suggested an increase in melting 
temperature and volatilization temperature of the treated 
sample as compared to the control sample. This was 
supported by DSC data of the samples.  
The derivative thermogravimetric (DTG) analysis of the 
control and treated samples are shown in Fig. 4. The DTG 
thermogram was used to record the maximum thermal 
decomposition temperature (Tmax) of the samples. The DTG 
thermogram of the control sample showed Tmax at 132.03°C 
and it was increased significantly to 163.45°C in the treated 
sample. Additionally, the onset of thermal degradation (Tonset) 
of the control sample was 93.61°C, and it was increased to 
133.64°C in the treated 2-AP. Overall, the increase in melting 
temperature, volatilization temperature, Tmax, and Tonset of the 
treated 2-AP indicated the much higher thermal stability of 
the sample as compared to the control. Researchers have 
shown that several factors contribute to thermostability of 
organic materials such as hydrophobicity [32], better 
packing, deletion or shortening of loops [33], smaller and 
less numerous cavities, increase surface area upon 
oligomerization [34], etc. Zhao et al. reported that three kinds 
of hydrogen bond binding sites are present in the 2-AP 
molecule [35]. Further, they elaborated that intermolecular 
hydrogen bonding is strengthened in the excited state. 
Therefore, it is hypothesized that biofield energy treatment 
improved the compactness and intermolecular hydrogen 
bonding in 2-AP that led to increase in thermal stability of 
the treated sample as compared to the control. 
Table 1. Thermal analysis data of control and treated 2-aminopyridine. 
Parameter Control Treated 
Latent heat of fusion ∆H (J/g) 155.99 151.18 
Melting temperature (°C) 60.90 61.32 
Tmax (°C) 132.03 163.45 
Weight loss (%) 67.01 44.64 
Tmax: maximum thermal decomposition temperature 
3.4. UV-visible Spectroscopy 
UV-visible analysis was used to investigate the chemical 
changes in the treated 2-AP as compared to the control 
sample. The UV spectra of control and treated 2-AP sample 
are presented in Fig. 5. The UV spectrum of control 2-AP 
showed two absorption peaks at 233 and 296 nm. However, 
the T1 sample showed absorption peaks at 234 and 298 nm. 
Whereas the T2 sample exhibited the absorption peaks at 233 
and 295 nm in the UV spectrum. Overall, the result showed 
no significant changes in the absorption peaks of the treated 
2-AP as compared to the control sample. Hence, the result 
demonstrated that biofield energy treatment had perhaps no 
effect on the energy gap of highest occupied molecular 
orbital and lowest unoccupied molecular orbital (HOMO–
LUMO gap) [36] of the treated 2-AP sample.  
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Fig. 4. TGA thermograms of control and treated 2-aminopyridine. 
3.5. FT-IR Spectroscopy 
FT-IR spectroscopy was used to elucidate the functional 
group changes in the sample after biofield treatment. FT-IR 
spectra of the control and treated 2-AP samples are presented 
in Fig. 6. FT-IR spectrum of the control 2-AP showed 
characteristic vibration peaks at 3448, 3284 and 3176 cm-1 
due to N-H asymmetric, N-H symmetric and N-H stretching 
vibrations, respectively. Whereas, in T1 and T2 these peaks 
were observed in the region of 3188-3444 cm-1 and 3192-
3452 cm-1, respectively. The vibration peaks at 2991, 2953 
and 2955 cm-1 were due to C-H stretching in the control, T1 
and T2 sample, respectively. The bands at 1624 and 987 cm-1 
were mainly due to the skeletal vibration of pyridine ring in 
the control [37,38], and T1 samples. The T2 showed these 
stretching vibrations at 1637 and 987 cm-1 in the sample. The 
absorption bands in the region of 1442-1489 cm-1, 1442-1487 
cm-1 and 1448-1485 cm-1 were due to asymmetrical C-H 
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stretching vibration peaks in control, T1, and T2 samples. 
The stretching vibration peak at 1064 cm-1 was due to C-N 
stretching vibration in the control and T2 sample, while in T1 
was observed at 1062 cm-1. The vibration peaks at 628-765 
cm-1 were attributed to the =C-H bending in the control, and 
T1 samples. Nevertheless, the T2 sample showed these 
vibration peaks at 628-777 cm-1. The stretching bands in the 
region of 520-565 cm-1 were due to out of plane ring (phenyl 
ring) deformation in the control and T1 samples. Whereas, in 
case of T2 sample it appeared at 522-628 cm-1. Overall the 
results revealed downward shifting of C-H stretching 
vibration 2991→2955 cm-1 in the treated sample as compared 
to the control sample. Besides this, no significant changes 
were observed in FT-IR spectrum of the treated sample with 
respect to the control. It is presumed that biofield energy 
treatment had perhaps altered the force constant or bond 
strength of the C-H bond in treated 2-AP as compared to the 
control sample.  
 
Fig. 5. UV spectra of control and treated 2-aminopyridine. 
4. Conclusions 
In summary, the results demonstrated that the biofield 
energy treatment has influenced the physical, thermal and 
spectral properties of 2-AP. The XRD study showed a 
decrease in crystallite size as well as an increase in Bragg’s 
angle (2θ) of the XRD peaks as compared to the control 
sample. It is speculated that biofield energy treatment may 
cause tensile stress in the treated 2-AP molecules that led to a 
shift in 2θ angle and decrease in crystallite size. The DSC 
and DTA exhibited the increase in melting temperature of the 
treated sample. However, the latent heat of fusion of the 
treated 2-AP was decreased as compared to the control. The 
biofield energy might have altered the stored internal energy 
in the treated sample that led to a reduction in latent heat of 
fusion. The TGA analysis showed an increase in onset of 
thermal degradation, Tmax, and reduction in weight loss of the 
treated 2-AP, which corroborated the high thermal stability of 
sample as compared to the control. The FT-IR results showed 
downward shifting in vibration bands of C-H group 
stretching as compared to the control. Overall, the result 
demonstrated that smaller crystallite size and good thermal 
stability (more temperature stable with higher reaction rate) 
might improve its applicability as better intermediate for the 
synthesis of pharmaceutical compounds.  
 
Fig. 6. FT-IR spectra of control and treated 2-aminopyridine. 
Abbreviations 
XRD: X-ray diffraction; DSC: Differential scanning 
calorimetry; TGA: Thermogravimetric analysis; FT-IR: 
Fourier transform infrared; UV: Ultra violet. 
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